PEX7

gene product
PTS2R, RD
This gene encodes the cytosolic receptor for the set of peroxisomal matrix enzymes targeted to the organelle by the peroxisome targeting signal 2 (PTS2). Defects in this gene cause peroxisome biogenesis disorders (PBDs), which are characterized by multiple defects in peroxisome function. There are at least 14 complementation groups for PBDs, with more than one phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene have been associated with PBD complementation group 11 (PBD-CG11) disorders, rhizomelic chondrodysplasia punctata type 1 (RCDP1), and Refsum disease (RD). [provided by RefSeq, Oct 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
57 antibodies from 19 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
antibodies-online
21 antibodies
Aviva Systems Biology
2 antibodies
Acris Antibodies GmbH
1 antibody
Novus Biologicals
3 antibodies
Biorbyt
4 antibodies
OriGene
2 antibodies
LifeSpan BioSciences, Inc.
7 antibodies
Thermo Fisher Scientific Pierce
2 antibodies
Bioworld Technology, Inc
1 antibody
Abnova Corporation
1 antibody
Proteintech Group
1 antibody
Atlas Antibodies
1 antibody
GeneTex
1 antibody
Creative Diagnostics
3 antibodies
RayBiotech, Inc.
1 antibody
EMD Millipore
1 antibody
RabMAbs
2 antibodies
UC Davis/NIH NeuroMab Facility
2 antibodies
Sigma-Aldrich
1 antibody